Above: Joshua Cooper prepares to administer a CT scan at the Central Arkansas Veterans Healthcare System. A VA study has found that smokers are often confused about the actual benefits and limitations of low-dose CT scans to screen for lung cancer. (Photo by Jeff Bowen, for illustrative purposes only.)

This article originally appeared in VA Research Currents.

Regular cancer screenings can lower the chance of death from lung cancer. But they cannot reduce the risk of developing lung cancer for people who smoke. Patients who smoke seem to be confused about the actual benefits and limitations of lung cancer screenings, according to a study by the VA Center of Innovation for Veteran-Centered and Value-Driven Care in Seattle.

Researchers asked smokers a series of questions about smoking and lung cancer screening. Their answers showed that most patients were mistaken about the benefits of such screenings and smoking in general. Only 7 percent of patients answered all five questions correctly.

In light of these findings, Dr. Jaimee L. Heffner, lead author on the paper, emphasized the importance of communicating to patients the importance of quitting rather than just relying on screenings to protect them from cancer. “Quitting smoking is by far the most important thing a person can do to prevent lung cancer as well as a host of other diseases caused by tobacco use, and it’s important that this message doesn’t get lost in the discussion of lung cancer screening,” he said. Heffner, with the Fred Hutchinson Cancer Research Center in Seattle, collaborated with the VA team on the study.

The results appeared online June 7, 2018, in the Annals of the American Thoracic Society.

In 2011, the National Cancer Institute released the results of its National Lung Screening Trial. The trial screened more than 53,000 current or former heavy smokers for lung cancer using either a standard chest X-ray or low-dose computed tomography. LDCT uses X-rays to take multiple scans of the entire chest, providing a more detailed image of the lungs than a single chest X-ray.

The study revealed that patients who had LDCT scans had a 15 to 20 percent lower risk of dying from lung cancer than those who had a standard chest X-ray. By giving a more complete picture of the chest and lungs, LDCT gives doctors a chance to catch and treat lung cancer more effectively than the old method.

As a result of this study, more LDCT lung cancer screenings have been implemented nationwide, including in VA. But while this type of screening can reduce deaths from lung cancer, it is unclear how well patients understand the benefits and limitations of LDCT scans.

To test patients’ actual knowledge about lung cancer, the researchers surveyed 83 smokers after they had an LDCT screening at one of four VA medical centers. Each participant was asked five questions:
1. Does having a lung cancer screening test decrease your chances of getting lung cancer? (Correct answer: No.)
2. Which disease is the leading cause of death in Americans who smoke cigarettes? (Correct answer: Heart disease [a list of diseases was provided].)
3. True or false: If nothing abnormal or suspicious is found on your lung cancer screening test, it means you are safe from lung cancer for at least 12 months. (Correct answer: False.)
4. True or false: All nodules or spots found in the lungs eventually grow over time to be life threatening. (Correct answer: False.)
5. For people over age 55 who are current smokers, which is more likely to prevent the most premature deaths—lung cancer screening or quitting smoking? (Correct answer: Quitting smoking.)

Almost all participants got at least one answer wrong. For the first question, 39 percent answered incorrectly. The majority, 66 percent, got question two wrong. Thirty-nine percent answered question 3 wrong, and 49 percent answered question four wrong. Perhaps most disturbing, nearly half (47%) answered the last question incorrectly, meaning they thought lung cancer screenings were at least as good as, if not better than, quitting smoking as a way of protecting against death.

To read the full article, click here to visit VA Research Currents.

Share this story

Published on Aug. 3, 2018

Estimated reading time is 3.3 min.

Views to date: 112

More Stories

  • New genetic research discoveries may one day help doctors better screen Veterans at risk of suicide and prevent it in the first place.

  • Greg Amira, Purple Heart Iraq Veteran and 9/11 survivor, became the 900,000th Veteran to join the Million Veteran Program.

  • A VA study has found that Pharmacogenomic, or genetic testing, can help providers avoid prescribing antidepressant medications that may have undesirable outcomes.